Mounjaro Mechanism of Action for Weight Loss (October 2026)

01 · The core answer

How Mounjaro makes you lose weight

Mounjaro helps you lose weight by helping to regulate appetite and slowing how quickly the stomach empties, which supports a reduced-calorie diet. Tirzepatide is the active ingredient, and it activates the GIP and GLP-1 receptors at the same time.¹

Tirzepatide is the first treatment of its kind to activate both of these natural gut-hormone receptors at once. Together they help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ Mounjaro is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

If you are comparing this with a single-action GLP-1 medicine, our guide to the differences between Mounjaro and Wegovy sets the two side by side.

02 · What to do next

Is this relevant to me, and what should I do next?

A prescriber decides whether Mounjaro suits you. It is licensed in the UK for weight management in adults and for type 2 diabetes, and it is a prescription-only medicine supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹

The practical next step is a free online consultation. The prescriber reviews your history, your other medicines and your goals, and decides whether treatment is appropriate. You can see current details on the Mounjaro pen page. Our weight loss clinic page explains how the service works alongside other options.

If you already take Mounjaro, your prescriber reviews your response and guides the pace of your dose steps.

03 · GIP and GLP-1 explained

GIP and GLP-1: the dual action

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. That is why it is described as a dual-action medicine.¹

Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ Our guide to the GLP-1 mechanism of action covers the GLP-1 pathway on its own, and the guide to GLP-1 analogues looks at medicines built around it.

The dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).¹

If you would like a visual walk-through, the GLP-1 mechanism animation guide breaks the sequence into steps.

04 · Appetite and fullness

What it feels like: appetite and fullness

In practice, most people feel fuller sooner and less hungry between meals.¹ Experiences differ widely between people.

The medicine slows how quickly the stomach empties, and this supports a reduced-calorie diet. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, not instead of them.²

The first weeks can look different from person to person. Some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.¹

Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹

05 · Versus other drugs

How it compares with other weight loss drugs

Mounjaro differs from semaglutide (Wegovy and Ozempic) because semaglutide is a single-action GLP-1 medicine, while tirzepatide activates GIP as well.¹ Both are once-weekly injections.

Liraglutide, supplied at a concentration of 6mg/ml, is another GLP-1 medicine, but it is a daily injection unlike once-weekly Mounjaro and Wegovy. For a deeper breakdown, see our guide to how Mounjaro differs from Ozempic.

Two GLP-1 weight-loss tablets, Wegovy tablets and Foundayo, are now licensed in the UK. They are different medicines from Mounjaro, with their own dosing, eligibility checks and trial results, and should not be compared with Mounjaro as if head to head. Our overview of emerging weight loss medicines keeps track of them. SURMOUNT-5 is the first large head-to-head trial of tirzepatide and semaglutide for weight loss, and your prescriber can discuss what it means for you.¹⁵

Mechanism differences do not decide the choice on their own. Tolerability, how you respond and your medical history all matter, so the decision belongs in a prescriber conversation.

06 · Questions for your prescriber

Questions to take to your prescriber

Always share your full medical history and medicine list during consultation, and take any questions about long-term effects, bowel conditions or what to eat to your prescriber, who knows your history.

Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.¹³

Report any new or lasting symptom to your prescriber, and you can report suspected side effects through the Yellow Card scheme.¹⁹ For severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis), get medical help straight away.¹³

Mounjaro (tirzepatide) is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

07 · Side effects and warning signs

Side effects and warning signs

Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.¹³

Serious side effects are uncommon but need urgent attention. Get medical help straight away (call 999 or go to A&E) for severe, persistent stomach pain that may spread to your back, with or without vomiting, which could be pancreatitis. Get medical help straight away for pain in the upper right abdomen, fever or yellowing of the skin or eyes, which could be gallbladder problems. Swelling of the face or throat and difficulty breathing are signs of a severe allergic reaction, so get medical help straight away.¹³

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion). Your prescriber may need to adjust those medicines.¹³

08 · Dose ladder

The dose ladder

Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself.¹

After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹ Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber will guide the right pace.¹¹

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹

09 · Using the pen

Using the pen day to day

Mounjaro is injected under the skin (subcutaneously) once a week, on the same day each week, at any time of day, with or without food. Each KwikPen contains four weekly doses. Rotate the site with each dose.¹

There is no "best" time of day — Mounjaro works the same morning or evening, with or without food. What matters is the same day each week.¹

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day — never take two doses within 3 days of each other.¹

You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹

Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use — useful for short trips — and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. Keep the pen cap on to protect it from light.¹

10 · What the trials measured

What the trials measured

The headline weight loss trial is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.¹

Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you (NICE TA1026).⁴

11 · Interactions and stopping

Interactions, clearance and stopping

Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose. Tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas, where doses may need reducing to avoid low blood sugar. No adjustment is needed for paracetamol.¹

Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. Prescribers advise switching to a non-oral method, or adding a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase. This applies to the pill only — implants, coils and injections are unaffected.¹⁷

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ Talk to your prescriber before stopping treatment.

Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.¹³

12 · Who should not take it

Who should not take Mounjaro

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.¹³

13 · NHS and private access

NHS and private access

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you go private, choose a GPhC-registered pharmacy, such as EverydayMeds (GPhC 9012878), and avoid anyone offering to supply without a consultation or prescription. We supply genuine KwikPens through official LillyDirect supply, with a free consultation reviewed by a GPhC-registered prescriber and ongoing monthly reviews.